Jazz Pharmaceuticals plc (JAZZ) : $21.94 million worth of transactions were on upticks in Jazz Pharmaceuticals plc (JAZZ), compared to $16.37 million on downticks. The ratio between the two was 1.34, whereas, the net money flow stood at a healthy $5.57 million on Tuesdays session.The block trades show a bullish bias with only $1.26 million worth of transactions done on downticks. The consistent buying on upticks in the stock accounted for $5.04million worth of trades. The up-down ratio between the uptick and downtick was 3.99, confirming that the stronger hands have been buying the stock on every weakness. The total money flow into the stock stood at $3.78 million. The bulls and the bears were in an equilibrium as the stock closed with a loss of -0.39%. The stock was trading at $126.23, with a drop of $0.5 over the previous days close. The stock recorded -1.78% for the week.
Also, Janney Capital initiates coverage on Jazz Pharmaceuticals plc (NASDAQ:JAZZ). The rating major has initiated the coverage with neutral rating on the shares. The rating by the firm was issued on August 25, 2016.
Jazz Pharmaceuticals Public Limited Company has lost 6.31% in the last five trading days and dropped 16.14% in the last 4 weeks. Jazz Pharmaceuticals Public Limited Company has dropped 18.41% during the last 3-month period . Year-to-Date the stock performance stands at -10.19%.
Jazz Pharmaceuticals plc (NASDAQ:JAZZ): The stock opened at $126.61 on Tuesday but the bulls could not build on the opening and the stock topped out at $127.56 for the day. The stock traded down to $125.82 during the day, due to lack of any buying support eventually closed down at $126.23 with a loss of -0.39% for the day. The stock had closed at $126.73 on the previous day. The total traded volume was 605,739 shares.
In a related news, The officer (SVP, Technical Operations), of Jazz Pharmaceuticals Plc, Treacy Paul had unloaded 1,292 shares at $137.46 per share in a transaction on August 16, 2016. The total value of transaction was $177,598. The Insider information was revealed by the Securities and Exchange Commission in a Form 4 filing.